Showing results (831-840 of 885) with videos related to

Sort By:
Pageof 89
Journal of Food Protection|July 31, 2026
Survival of Escherichia coli TVS353 in southeastern U.S. soils amended with heat-treated poultry pellets and composted poultry litter: influence of location and soil nutrient composition on population dynamicsCharles B Appolon, Harsimran K Kapoor, Amelia K Payne, et al.
Annals of Surgery|October 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant ChemotherapyDominic J Vitello, Dhavan Shah, Amy Wells, et al.
United European Gastroenterology Journal|December 17, 2025
Performance of GPT-5 in the Interpretation of IBD Histopathology ReportsMarcello Maida, Alessandro Vitello, Fabio Salvatore Macaluso, et al.
Journal of Hospital Medicine|August 10, 2023
In their own words: Safety and quality perspectives from families of hospitalized children with medical complexitySangeeta Mauskar, Tiffany Ngo, Helen Haskell, et al.
Obstetrics and Gynecology|November 26, 2019
Stillbirth Associated With Infection in a Diverse U.S. CohortJessica M Page, Tyler Bardsley, Vanessa Thorsten, et al.
Frontiers in Immunology|July 16, 2025
Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samplesVishal Rathod, Sagar Katke, Sumant Patil, et al.
Hormone Research in Paediatrics|April 30, 2014
Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for useT C J Sas, E J Gault, M Zeger Bardsley, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratificationA Laroni, C G Giacomazzi, L Grimaldi, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2018
Managing emerging mutagenicity risks: Late stage mutagenic impurity control within the atovaquone second generation synthesisMichael W J Urquhart, Ben Bardsley, Andrew J Edwards, et al.
Respiratory Medicine|December 5, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysisSamuel Bardsley, Gerard J Criner, David M G Halpin, et al.
Pageof 89